Erik Pålsson Selected Research

Phencyclidine (Angel Dust)

3/2011	Prefrontal NMDA receptor antagonism reduces impairments in pre-attentive information processing.
12/2010	Information processing deficits and nitric oxide signalling in the phencyclidine model of schizophrenia.
12/2009	Increased cortical nitric oxide release after phencyclidine administration.
6/2009	The importance of nitric oxide in social dysfunction.
6/2009	Prefrontal GABA(B) receptor activation attenuates phencyclidine-induced impairments of prepulse inhibition: involvement of nitric oxide.
8/2008	Agmatine attenuates the disruptive effects of phencyclidine on prepulse inhibition.
5/2008	Nitric oxide synthase inhibition attenuates phencyclidine-induced disruption of cognitive flexibility.
5/2007	The amino acid L-lysine blocks the disruptive effect of phencyclidine on prepulse inhibition in mice.
4/2007	The atypical antipsychotic, aripiprazole, blocks phencyclidine-induced disruption of prepulse inhibition in mice.
11/2006	Phencyclidine affects memory in a nitric oxide-dependent manner: working and reference memory.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erik Pålsson Research Topics

Disease

22	Bipolar Disorder (Manic Depressive Psychosis) 09/2022 - 06/2013
14	Schizophrenia (Dementia Praecox) 12/2015 - 02/2005
7	Cognitive Dysfunction 08/2015 - 07/2006
3	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 05/2007
2	Mood Disorders (Mood Disorder) 01/2021 - 01/2015
2	Mental Disorders (Mental Disorder) 01/2021 - 02/2016
1	Fibrosis (Cirrhosis) 01/2022
1	Genetic Risk Score 01/2021
1	Cicatrix (Scar) 01/2021
1	Personality Disorders (Personality Disorder) 01/2021
1	Neurodevelopmental Disorders 01/2021
1	Neuroinflammatory Diseases 08/2015
1	Nervous System Diseases (Neurological Disorders) 05/2015
1	Alcoholism (Alcohol Abuse) 05/2015
1	Inflammation (Inflammations) 01/2015
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2014
1	Alzheimer Disease (Alzheimer's Disease) 10/2014
1	Neurobehavioral Manifestations 10/2014
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 04/2011
1	Brain Diseases (Brain Disorder) 08/2008

Drug/Important Bio-Agent (IBA)

11	Phencyclidine (Angel Dust)IBA 03/2011 - 07/2006
6	Biomarkers (Surrogate Marker)IBA 09/2022 - 10/2014
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2015 - 05/2008
5	Antipsychotic Agents (Antipsychotics)IBA 01/2015 - 02/2005
5	Pharmaceutical PreparationsIBA 12/2010 - 04/2007
4	Proteins (Proteins, Gene)FDA Link 09/2022 - 01/2015
4	LithiumIBA 01/2022 - 01/2015
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 03/2011 - 07/2006
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 05/2014
3	Amino Acids FDA Link 06/2016 - 04/2011
3	Glutamic Acid (Glutamate)FDA Link 01/2015 - 06/2009
2	CytokinesIBA 01/2021 - 01/2015
2	Calcium Channels (Calcium Channel)IBA 12/2019 - 02/2016
2	Dopamine (Intropin)FDA LinkGeneric 12/2015 - 04/2011
2	Amyloid (Amyloid Fibrils)IBA 01/2015 - 10/2014
2	Nitric Oxide Synthase (NO Synthase)IBA 12/2010 - 06/2009
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Chitinase-3-Like Protein 1IBA 01/2022
1	AdrenomedullinIBA 01/2022
1	ChemokinesIBA 01/2022
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 01/2022
1	picolinic acid (chromium picolinate)IBA 01/2021
1	3,4-methylenedioxyethamphetamine (MDEA)IBA 01/2021
1	Methanol (Carbinol)IBA 01/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	Kynurenic Acid (Kynurenate)IBA 01/2021
1	KynurenineIBA 01/2021
1	Tryptophan (L-Tryptophan)FDA Link 01/2021
1	Quinolinic AcidIBA 01/2021
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2021
1	MethoxyhydroxyphenylglycolIBA 01/2017
1	AcidsIBA 01/2017
1	Homovanillic AcidIBA 01/2017
1	Urea (Carbamide)FDA LinkGeneric 06/2016
1	Transcription Factors (Transcription Factor)IBA 12/2015
1	Neuregulin-1 (Neuregulin 1)IBA 12/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2015
1	AntioxidantsIBA 05/2015
1	Interleukin-8 (Interleukin 8)IBA 01/2015
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2015
1	Glutamine (L-Glutamine)FDA Link 01/2015
1	Serine (L-Serine)FDA Link 01/2015
1	Amyloid beta-PeptidesIBA 01/2015
1	Neuropeptide YIBA 12/2014
1	ApolipoproteinsIBA 10/2014
1	flutemetamolIBA 10/2014
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 10/2014
1	Apolipoproteins E (ApoE)IBA 10/2014
1	CarbonIBA 10/2014
1	Glucose (Dextrose)FDA LinkGeneric 05/2013
1	Oxygen (Dioxygen)IBA 05/2013
1	Lysine (L-Lysine)FDA Link 04/2011
1	gamma-Aminobutyric Acid (GABA)IBA 06/2009
1	AgmatineIBA 08/2008
1	Neurotransmitter Agents (Neurotransmitter)IBA 08/2008
1	Hallucinogens (Psychedelics)IBA 05/2008

Therapy/Procedure

1	Therapeutics 12/2010